These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 28030805)

  • 1. TIMP-1 and CD82, a promising combined evaluation marker for PDAC.
    Zhang J; Wu T; Zhan S; Qiao N; Zhang X; Zhu Y; Yang N; Sun Y; Zhang XA; Bleich D; Han X
    Oncotarget; 2017 Jan; 8(4):6496-6512. PubMed ID: 28030805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver.
    Grünwald B; Harant V; Schaten S; Frühschütz M; Spallek R; Höchst B; Stutzer K; Berchtold S; Erkan M; Prokopchuk O; Martignoni M; Esposito I; Heikenwalder M; Gupta A; Siveke J; Saftig P; Knolle P; Wohlleber D; Krüger A
    Gastroenterology; 2016 Nov; 151(5):1011-1024.e7. PubMed ID: 27506299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Linc00675 is a novel marker of short survival and recurrence in patients with pancreatic ductal adenocarcinoma.
    Li DD; Fu ZQ; Lin Q; Zhou Y; Zhou QB; Li ZH; Tan LP; Chen RF; Liu YM
    World J Gastroenterol; 2015 Aug; 21(31):9348-57. PubMed ID: 26309360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmembrane interactions are needed for KAI1/CD82-mediated suppression of cancer invasion and metastasis.
    Bari R; Zhang YH; Zhang F; Wang NX; Stipp CS; Zheng JJ; Zhang XA
    Am J Pathol; 2009 Feb; 174(2):647-60. PubMed ID: 19116362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpressed EDIL3 predicts poor prognosis and promotes anchorage-independent tumor growth in human pancreatic cancer.
    Jiang SH; Wang Y; Yang JY; Li J; Feng MX; Wang YH; Yang XM; He P; Tian GA; Zhang XX; Li Q; Cao XY; Huo YM; Yang MW; Fu XL; Li J; Liu DJ; Dai M; Wen SY; Gu JR; Hong J; Hua R; Zhang ZG; Sun YW
    Oncotarget; 2016 Jan; 7(4):4226-40. PubMed ID: 26735172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kif20a inhibition reduces migration and invasion of pancreatic cancer cells.
    Stangel D; Erkan M; Buchholz M; Gress T; Michalski C; Raulefs S; Friess H; Kleeff J
    J Surg Res; 2015 Jul; 197(1):91-100. PubMed ID: 25953216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TIMP1 Triggers Neutrophil Extracellular Trap Formation in Pancreatic Cancer.
    Schoeps B; Eckfeld C; Prokopchuk O; Böttcher J; Häußler D; Steiger K; Demir IE; Knolle P; Soehnlein O; Jenne DE; Hermann CD; Krüger A
    Cancer Res; 2021 Jul; 81(13):3568-3579. PubMed ID: 33941611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The palmitoylation of metastasis suppressor KAI1/CD82 is important for its motility- and invasiveness-inhibitory activity.
    Zhou B; Liu L; Reddivari M; Zhang XA
    Cancer Res; 2004 Oct; 64(20):7455-63. PubMed ID: 15492270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of KAI1/CD82 on the beta1 integrin maturation in highly migratory carcinoma cells.
    Jee BK; Lee JY; Lim Y; Lee KH; Jo YH
    Biochem Biophys Res Commun; 2007 Aug; 359(3):703-8. PubMed ID: 17560548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissecting the diverse functions of the metastasis suppressor CD82/KAI1.
    Tsai YC; Weissman AM
    FEBS Lett; 2011 Oct; 585(20):3166-73. PubMed ID: 21875585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High STMN1 Expression Is Associated with Tumor Differentiation and Metastasis in Clinical Patients with Pancreatic Cancer.
    Suzuki K; Watanabe A; Araki K; Yokobori T; Harimoto N; Gantumur D; Hagiwara K; Yamanaka T; Ishii N; Tsukagoshi M; Igarashi T; Kubo N; Gombodorj N; Nishiyama M; Hosouchi Y; Kuwano H; Shirabe K
    Anticancer Res; 2018 Feb; 38(2):939-944. PubMed ID: 29374725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastasis suppressor KAI1/CD82 attenuates the matrix adhesion of human prostate cancer cells by suppressing fibronectin expression and β1 integrin activation.
    Lee HA; Park I; Byun HJ; Jeoung D; Kim YM; Lee H
    Cell Physiol Biochem; 2011; 27(5):575-86. PubMed ID: 21691075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Papillary carcinoma of the thyroid: high expression of COX-2 and low expression of KAI-1/CD82 are associated with increased tumor invasiveness.
    Scarpino S; Duranti E; Giglio S; Di Napoli A; Galafate D; Del Bufalo D; Desideri M; Socciarelli F; Stoppacciaro A; Ruco L
    Thyroid; 2013 Sep; 23(9):1127-37. PubMed ID: 23617728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KAI1/CD82 suppresses tumor invasion by MMP9 inactivation via TIMP1 up-regulation in the H1299 human lung carcinoma cell line.
    Jee BK; Park KM; Surendran S; Lee WK; Han CW; Kim YS; Lim Y
    Biochem Biophys Res Commun; 2006 Apr; 342(2):655-61. PubMed ID: 16488391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomic Detection Between Pancreatic Cancer and Liver Metastasis Nude Mouse Models Constructed by Using the PANC1-KAI1/CD
    Wang S; Chen J; Li H; Qi X; Liu X; Guo X
    Technol Cancer Res Treat; 2021; 20():15330338211045204. PubMed ID: 34605330
    [No Abstract]   [Full Text] [Related]  

  • 16. Unique metabolic features of pancreatic cancer stroma: relevance to the tumor compartment, prognosis, and invasive potential.
    Knudsen ES; Balaji U; Freinkman E; McCue P; Witkiewicz AK
    Oncotarget; 2016 Nov; 7(48):78396-78411. PubMed ID: 27623078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β2-adrenergic receptor signaling promotes pancreatic ductal adenocarcinoma (PDAC) progression through facilitating PCBP2-dependent c-myc expression.
    Wan C; Gong C; Zhang H; Hua L; Li X; Chen X; Chen Y; Ding X; He S; Cao W; Wang Y; Fan S; Xiao Y; Zhou G; Shen A
    Cancer Lett; 2016 Apr; 373(1):67-76. PubMed ID: 26803058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KAI1/CD82, a tumor metastasis suppressor.
    Liu WM; Zhang XA
    Cancer Lett; 2006 Aug; 240(2):183-94. PubMed ID: 16260083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single nucleotide polymorphism in the microRNA-199a binding site of HIF1A gene is associated with pancreatic ductal adenocarcinoma risk and worse clinical outcomes.
    Wang X; Ren H; Zhao T; Ma W; Dong J; Zhang S; Xin W; Yang S; Jia L; Hao J
    Oncotarget; 2016 Mar; 7(12):13717-29. PubMed ID: 26872370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Downregulation of RPL15 may predict poor survival and associate with tumor progression in pancreatic ductal adenocarcinoma.
    Yan TT; Fu XL; Li J; Bian YN; Liu DJ; Hua R; Ren LL; Li CT; Sun YW; Chen HY; Fang JY; Hong J
    Oncotarget; 2015 Nov; 6(35):37028-42. PubMed ID: 26498693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.